The IBSA Satellite Symposium held in Dubrovnik, during the EFIC 2016 Congress, focused on the novelties in GAGs therapy, in particular on chondroitin sulfate (CS) and hyaluronic acid (HA). In the session, chaired by Dr. Chris Wells, new clinical data for CS and the “Hybrid Cooperative Complexes” (NAHYCO™), the new generation of intra-articular HA, have been presented and discussed.
The IBSA Satellite Symposium held in Dubrovnik, during the EFIC 2016 Congress, focused on the novelties in GAGs therapy, in particular on chondroitin sulfate (CS) and hyaluronic acid (HA). In the session, chaired by Dr. Chris Wells, new clinical data for CS and the “Hybrid Cooperative Complexes” (NAHYCO™), the new generation of intra-articular HA, have been presented and discussed.
full talks
Welcome and Introduction
Introduction to the "GAGs world": from structure to action
The clinical benefits of chondroitin sulphate and HA in osteoarthritis
What's new in OA joint pain treatment: HiLow hyaluronic acid
Discussion and Conclusion
interviews with speakers
Chondroitin sulfate and intra-articular HA are important in OA management
From research, novel GAG formulations against osteoarthritis
Considerations on the efficacy of chondroitin sulfate and hyaluronic acid in OA
